The ABL genes in normal and abnormal cell development

Critical Reviews in Oncogenesis

Volumn 7, Issue 1-2, 1996, Pages 33-48

  Chung, Siu Wah ^a   Daniel, Rene ^a   Wong, Bryan Y ^a   Wong, Peter M C ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; bcr abl; c abl; c abl isoforms; chronic myelogenous leukemia; hematopoietic stem cells; oncogene; stromal cells; v abl

Indexed keywords

BCR ABL PROTEIN; ONCOPROTEIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; GENE MUTATION; HUMAN; ONCOGENE; PROTO ONCOGENE; REVIEW; STROMA CELL;

EID: 0030429530     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v7.i1-2.30     Document Type: Review

References (184)

1. Aaltonen, L. A., P. Peltomaki, F. S. Leach, P. Sistonen, L. Pylkkanen, J-P. Mecklin, H. Jarvinen, S. M. Powell, J. Jen, R. Hamilton, G. M. Peteresen, K. W. Kinzler, B. Vogelstein, and A. de la Chappelle:Clues to the pathogenesis of familial colorectal cancer. Science, 260:812-816 (1993).
2. Abelson, H. T. and L. S. Rabstein:Lymphosarcoma virus: virus-induced thymic independent disease in mice. Cancer Res., 30:2213-2222 (1970).
3. Adams, J. C. and F. W. Watt:Regulation of development and differentiation by the extracellular matrix. Development, 117:1183-1198 (1993).
4. Adkins, B., A. Leutz, and T. Graf:Autocrine growth induced by src-related oncogene in transformed chicken myeloid cells. Cell, 39:439-445 (1984).
5. Ahuja, H., M. Bar-Eli, S. H. Advani, S. Benchimol, and M. J. Cline:Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A., 86:6783-6787 (1989).
6. Ahuja, H., M. Bar-Eli, Z. Arlin, S. Advani, S. L. Allen, J. Goldman, D. Snyder, A. Foti, and M. J. Cline:The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest., 87:2042 (1991).
7. Argyriou-Tirita, A., K. Romanakis, P. Kroisel, and O. A. Haas:Asynchronous replication patterns of imprinted genes in triploid cells. In: Genomic Priority Reports, Vol. 2: Genomic Imprinting and New Approaches in Identification and Mapping of Genetic Syndromes (Giovannu Uzielle et al., Ed.) Karger, Basel, in press.
8. Barlow, D. P., R. Stoger, B. G. Hermann, K. Saito, and N. Schweifer:The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the TME locus. Nature., 349:84-87 (1991).
9. Bartolomei, M. S., S. Zemel, and S. M. Tilghman:Parental imprinting of the H19 gene. Nature, 351:153-155 (1991).
10. Bedi, A., B. A. Zennbauer, M. I. Collector, J. P. Barber, M. S. Zicha, S. J. Sharkis, and R. J. Jones:BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood, 81:2898-2902 (1993).
11. Ben-Neriah, Y., A. Bernards, M. Paskind, G. Q. Daley, and D. Baltimore:Alternative 5′-exons in c-abl mRNA. Cell, 44:577-586 (1986).
12. Bergold, P. J., J. A. Blumenthal, E. D'Andrea, H. W. Snyder, L. Lederman, A. Silverstone, H. Nguyen, and P. Besmer: Nucleic acid sequence and oncogenic properties of the HZII feline sarcoma virus v-abl insert. J. Virol., 61:1193-1202 (1987).
13. Besmer, P., W. D. Hardy, Jr., E. E. Zuckerman, P. J. Bergold, L. Lederman, H. W. Snyder, Jr.:The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV. Nature, 303:825-828 (1983).
14. Bhatia, R., E. A. Wayner, P. B. McGlave, and C. M. Verfaillie:Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow by correcting impaired β1 integrin receptor function. J. Clin. Invest., 94:384-391 (1994).
15. Bhatia, R., P. B. McGlave, G. W. Dewald, B. R. Blazer, and C. M. Verfaillie:Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood, 85:3636-3645 (1995).
16. Campbell, A. D., M. W. Long, and M. S. Wicha:Hemonectin, a bone marrow adhesion protein specific for cells of the granulocytic lineage. Nature, 329:744-746 (1987).
17. Caracciolo, D., M. Valtiri, D. Venturelli, C. Peschle, A. M. Gewirtz, and B. Calabretta:Lineage-specific requirement of c-abl function in normal hematopoiesis. Science, 245:1107-1110 (1989).
18. Carlo-Stella, C., L. Mangoni, G. Piovanni, D. Garau, C. Almici, and A. V. Rizzoli:Identification of Philadelphia-negative granulocyte-rnacrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood, 83:1373-1380 (1994).
19. Cashman, J., A. C. Eaves, and C. J. Eaves:Regulated proliferation of primitive hematopoietic progenitors in long-term human marrow cultures. Blood, 66:1002-1005 (1985).
20. Chabannon, C. and B. Torok-Storb:Stem cell-stromal cell interactions. Curr. Top. Micro. Immunol., 177:123-136 (1992).
21. Chan, L. C., K. K. Karhi, S. I. Rayter, N. Heisterkamp, S. Eridani, R. Powles, S. D. Lawler, J. Groffen, J. G. Foulkes, M. F. Greaves, and L. M. Wiedemann:A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukemia. Nature, 325:635-637 (1987).
22. Chen, Y. and N. Rosenberg:Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Proc. Natl. Acad. Sci. U.S.A., 89:6683-6687 (1992).
23. Chung, S. W. and P. M. C. Wong:The biology of Abl during hemopoietic stem cell differentiation and development. Oncogene, 10:1261-1268 (1995).
24. Cluing, S. W., Y. L. Cai, R. Nyein, E. Brizzolara, K. de Riel, and P. M. C. Wong:Endogenous growth factor patterns modulate hemopoietic lineage development. Oncogene, 9:3527-3533 (1994).
25. Chung, S. W., P. M. C. Wong, G. Shen-Ong, S. Ruscetti, T. Ishizaka, and C. J. Eaves:Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood, 68:1074-1081 (1986).
26. Chung, S. W., S. Ruscetti, and P. M. C. Wong:Formation of factor-independent hematopoietic multilineage colonies after Abelson virus infection. Blood, 71:973-977 (1988).
27. Chuug, S. W., P. M. C. Wong, H. Durkin, Y. S. Wu, and J. Petersen:Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene. Proc. Natl. Acad. Sci. U.S.A., 88:1585-1589 (1991).
28. 1-positive ALL. Science, 235:85-88 (1987).
29. Cook, W. D.:Rapid thyrnomas induced by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. U.SA., 79:2917-2921 (1982).
30. Cook, W. D., D. Metcalf, N. A. Nicola, A. W. Burgess, and F. Walker:Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell, 41:677-683 (1985).
31. Cortez, D., L. Kadlec, and A. M. Pendergast:Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol., 15:5531-5541 (1995).
32. Coulombel, L., Vuillet, M. H., Leroy, C., and G. Tchernia:Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts. Blood, 71:329-334 (1988).
33. bcr/abl gene of the Philadelphia chromosome. Science, 247:824-830 (1990).
34. bcr/abl protein. Proc. Natl. Acad. Sci. U.SA., 85:9312-9316 (1988).
35. Danial, N. N., A. Penis, and P. B. Rothman:Jak-STAT signaling induced by the v-abl oncogene. Science, 269:1875-1877 (1995).
36. Daniel, R., Y. Cai, P. M. C. Wong, and S. W. Chung:Deregulation of c-abl-mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene, 10:1607-1614 (1995).
37. Daniel, R., S. W. Chung., H. Chen, and P. M. C. Wong:Reduction of c-abl induces apoptosis. (submitted.)
38. DeChiara, T. M., E. J. Robertson, and A. Efstratiadis:Parental imprinting of the mouse insulin like growth factor II gene. Cell, 64:849-859 (1991).
39. Diamond, J., J. M. Goldman, and J. V. Melo:BCR-ABI., ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood, 85:2171-2175 (1995).
40. Dowding, C., A-P. Guo, J. Osterholz, M. Siczkowski, J. Goldman, and M. Gordon:Interferon-α, overrides the deficient adhesion of chronic myeloid leukemia primitive progenitors to bone marrow stromal cells. Blood, 78:499-505 (1991).
41. Dryja, T. P., S. Mukai, R. Poetersen, J. M. Rapaport, D. Walton, and D. W. Yandell: Parental origin of mutations of the retinoblastoma gene. Nature, 339:556-558 (1989).
42. Elefanty, A. G., I. K. Hariharan, and S. Cory:BCR/ABL, the hallmark of chronic myeloid leukemia in man, induces multiple hemopoietic neoplasms in mice. EMBO J., 9:1069-1078 (1990).
43. Farmer, G. J., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Priwes:Wild-type p53 activates transcription in vitro. Nature, 358:83-86 (1992).
44. Fialkow, P. J., R. J. Jacobson, and T. Papayannopoulou:Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med., 63:125-130 (1977).
45. Fialkow, P. J., A. M. Denman, R. J. Jacobson, and M. N. Lowenthal:Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J. Clin. Invest., 62:815-823 (1978).
46. Fioretos, T., N. Heisterkamp, and J. Groffen:No evidence for genomic imprinting of the human BCR gene. Blood, 83:3441-3444 (1994).
47. Fishel, R., M. K. Lescoe, M. R. S. Rao, N. G. Copeland, N. A. Jenkins, J. Garber, M. Kane, and R. Kolodner:The mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75:1027-1038 (1993).
48. Franz, W. M., P. Berger, and J. Y. J. Wang:Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J., 8:137-147 (1989).
49. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren:Wild type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. U.S.A., 88:9979-9983 (1989).
50. Goff, S. P., P. D'Eustachio, F. Ruddle, and D. Baltimore:Chromosomal assignment of the endogenous protooncogene c-abl. Science, 218:1317-1319 (1982).
51. Gishizky, M. L. and O. N. Witte:Initiation of deregulated growth of multipotent progenitor cells by BCR/ABL in vitro. Science, 256:836-839 (1992).
52. Gishizky, M. L., J. Johnson-White, and O. N. Witte:Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc. Natl. Acad. Sci. U.S.A., 90:3755-3759 (1993).
53. Gold, J. D. and R. A. Pedersen:Mechanisms of genomic imprinting in mammals. Curr. Top. Dev. Biol., 29:227-281 (1994).
54. Gonzalez-Zulueta, M., J. M. Ruppert, K. Tokino, Y. C. Tsai, C. H. Spruck, III, N. Miyao, P. W. Nichols, G. G. Hermann, T. Horn, K. Steven, I. C. Summerhayes, D. Sidransky, and P. A. Jones:Microsatellite instability in bladder cancer. Cancer Res., 53:5620-5623 (1993).
55. Gordon, M. Y., C. R. Dowding, G. P. Riley, J. M. Goldman, and M. F. Greaves:Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukemia. Nature, 328:342-344 (1987).
56. Gordon, M. Y., C. R. Dowding, G. P. Riley, J. M. Goldman, and M. F. Greaves:Adhesive defects in chronic myeloid leukemia. Curr. Top. Micro. Immunol., 149:153-155 (1989).
57. Grundy, P., A. Koufos, K. Morgan, F. P. Li, A. T. Meadows, and W. K. Cavence:Familial predisposition to Wilms' tumor does not map to the short arm of chromosome 11. Nature, 336:374-376 (1988).
58. Haas, O. A.:Are ABL and BCR imprinted? No definitive answers, but more questions. Leukemia, 9:740-743 (1995).
59. Haas, O. A., A. Argyriou, and T. Lion:Parental origin of chromosomes involved in the translocation t(9;22). Nature, 359:414-416 (1992).
60. Hall, J.:Genomic imprinting: review and relevance to human diseases. Am. J. Hum. Genet., 46:857-873 (1990).
61. Han, H-J., A. Yanagisawa, Y. Kato, J-G. Park, and Y. Nakamura:Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res., 53:5087 (1993).
62. Han, X., P. M. C. Wong, and S. W. Chung:Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hernopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A., 88:10129-10133 (1991).
63. Heisterkamp, N., J. Groffen, J. Stephenson, N. Spurr, P. Goodfellow, E. Solomon, B. Carrit, and W. Bodmer:Chromosomal localization of human cellular homologues of two viral oncogenes. Nature, 299:747-749 (1982).
64. Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. Pattengale, and J. Groffin:Acute leukemia in bcr/abl transgenic mice. Nature, 344:251-253 (1990).
65. Hockenberry, D., G. Nunez, C. Millima, R. D. Schreiber, and S. J. Korsmeyer:Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 248:334-336 (1991).
66. Hollstein, M., D. Sidranski, B. Vogelstein, and C. Harris: p53 mutations in human cancer. Science, 253:49-53 (1991).
67. Huff, V., D. A. Compton, L-Y. Chao, L. C. Strong, C. F. Geiser, and G. F. Saunders:Lack of linkage of familial Wilms' tumor to chromosomal band 11p13. Nature, 336:377-378 (1988).
68. Ionov, Y., M. A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho:Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363:558 (1993).
69. Jackson, P. and D. Baltimore:N-terminal mutations activate the leukemogenic potential of the myristyolated form of c-abl. EMBO J., 8:449-456 (1989).
70. Jiang, X. Y., J. M. Trujillo, and J. C. Jiang:Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia. Blood, 76:597-601 (1990).
71. + chronic myeloid leukemia. Exp. Hematol., 19:539 (1991).
72. + cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood, 83:1744-1749 (1994).
73. Kelliher, M. A., J. McLaughlin, O. N. Witte, and N. Rosenberg:Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and bcr/abl. Proc. Natl. Acad. Sci. U.S.A., 87: 6649-6653 (1990).
74. Kelliher, M. A., A. Knott, J. McLaughlin, O. N. Witte, and N. Rosenberg:Differences in oncogenic potency but not target cell specificity distinguish the two forms of BCR/ABL oncogeue. Mol. Cell. Biol., 11:4710-4716 (1991).
75. Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima:Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J., 14:266-275 (1995).
76. Kipreos, E. T. and J. Y. J. Wang:Differential phosphorylation of c-abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science, 248:217-220 (1990).
77. Kipreos, E. T. and J. Y. J. Wang:Cell cycle-regulated binding of c-abl tyrosine khiase to DNA. Science, 256:382-385 (1992).
78. Kitsberg, D., S. Selig, M. Brandeis, I. Simon, I. Keshel, D. J. Driscoll, R. D. Nicholls, and H. Cedar:Allele-specific replication timing of imprinted gene regions. Nature, 364:459-463 (1993).
79. Konopka, J. B. and O. N. Witte:Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol., 11:3116-3123 (1985).
80. Konopka, J. B., S. Watanabe, and O. N. Witte:An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37:1035-1042 (1984).
81. Koury, M. J.:Programmed cell death (apoptosis) in hematopoiesis. Exp. Hematol., 20:391-394 (1992).
82. Koury, M. J. and M. C. Bondmant:Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science, 248:378-381 (1990).
83. Kurzrock, R., M. Shtalrid, P. Romero, W. S. Kleotzer, M. Talpas, J. M. Trujillo, and J. U. Gutterman:A novel c-abl protein product in Philadelphia positive acute lymphoblastic leukemia. Nature, 325:631-635 (1987).
84. Lane, D. P. and L. V. Crawford:T antigen is bound to a host protein in SV40-transformed cells. Nature, 278:261-263 (1979).
85. Lane, D. and S. Benchimol: p53: oncogene or anti-oncogene? Oncogene, 4:1-8 (1990).
86. Launeville, P., M. Timm, and A. Hudson:BCR/ABL expression in 32Dc13(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Cancer Res., 54:1360-1366 (1994).
87. Leach, R. J., A. N. Magewu, J. D. Buckley, W. F. Benedict, C. Rother, A. L. Murphree, S. Griegel, M. F. Rajewsky, and P. A. Jones:Preferential retention of paternal alleles in human retinoblastoma: evidence for genomic imprinting. Cell Growth Different., 1:401-406 (1990).
88. Lee, J. C., A. J. Hapel, and J. N. Ihle:Constitutive production of a unique lymphokine (IL-3) by the WEHI-3 cell line. J. Immunol., 128:2393-2398 (1982).
89. Leff, S. E., C. I. Brannan, M. L. Reed, T. Ozcelik, U. Francke, N. G. Copeland, and N. A. Jenkins:Maternal imprinting of the mouse Snrpn gene and conserved linkage homology with the human Prader-Willi syndrome region. Nature Genet., 2:259-264 (1992).
90. Le vine, A. J., J. Momand, and C. A. Finland:The p53 tumor suppressor gene. Nature, 351:453-456 (1991).
91. Linzer, D. I. H. and A. J. Levine:Characterization of a 54 kDa cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17:47-52 (1979).
92. Litz, C. E.:The parental origin of the Philadelphia chromosome: evidence of additional, recurring recombinatorial events. Leukemia, 9:744-745 (1995).
93. Litz, C. E. and C. M. Copenhaver:Paternal origin of the rearranged major breakpoint cluster region in chronic myeloid leukemia. Blood, 83:3445-3448 (1994).
94. Litz, C. E., A. N. Goldfarb, J. G. Srickler, and R. D. Brunning:Presence of cell lineage specific hypomethylated sites in the major breakpoint cluster region. Cancer Res., 50:4984-4990 (1990).
95. Liu, E., B. Hjelle, and J. M. Bishop:Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. U.S.A., 85:1952-1956 (1988).
96. Lobb, R. R. and M. E. Hemler:The pathophysiologic role of the alpha 4 integrins in vivo. J. Clin. Invest., 94:1722-1728 (1994).
97. Long, M. W.:Blood cell cytoadhesion molecules. Exp. Hematol., 20:288-301 (1992).
98. Lugo, T. G., A. M. Pendergast, A. J. Muller, and O. N. Witte:Tyrosine kinase activity and transformation potency of bcr-abl products. Science, 247:1079-1082 (1990).
99. May, W. S., P. G. Tyler, T. Ito, D. K. Armstrong, K. A. Qatsha, and N. E. Davidson:Interleukin-3 and Bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis. J. Biol. Chem., 269:26865-26870 (1994).
100. McCormick, P. and E. Harlow:Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J. Virol., 34:213-224 (1980).
101. McGahon, A., R. Bissonnette, M. Schmitt, K. M. Cotter, D. R. Green, and T. G. Cotter:BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83:1179-1187 (1994).
102. McWhirter, J. R. and J. Y. L. Wang:Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol., 11:1553-1565 (1991).
103. McWhirter, J. R. and J. Y. L. Wang:An actin binding function contributes to transformation by the BCR/ABL oncoprotein of Philadelphia chromosome positive human leukemias. EMBO J., 12:1533-1546 (1993).
104. Melo, J. V. and J. M. Goldman:Reply to Haas: Are ABL and BCR imprinted? (Leukemia, 9:740-743 [1995]) Leukemia, 9:1407-1408 (1995).
105. Mendoza, G. R. and H. Metzger:Disparity of IgE binding between normal and tumor mouse mast cells. J. Immunol., 117:1573-1578 (1976).
106. Migone, T-S., J-X. Lin, A. Cereseto, J. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard:Constitutive activated Jak-STAT pathway in T cells transformed with HTLV-1. Science, 269:79-83 (1995).
107. Muller, R., D. J. Slamon, J. M. Tremblay, M. J. Cline, and I. Verma:Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature, 299:640-644 (1982).
108. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pendel, N. R. Landau, D. R. Littman, and O. N. Witte:BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome positive human leukemia. Mol. Cell. Biol., 11:1785-1792 (1991).
109. Nicolaides, N. C., N. Papadopoulous, B. Liu, Y-F. Wei, K. C. Carter, S. M. Ruben, C. A. Rosen, W. A. Haseltine, R. D. Fleishmann, C. M. Fraser, M. D. Adams, J. C. Venter, M. J. Dunlop, S. R. Hamilton, G. M. Petersen, A. de la Chapelle, B. Vogelstein, and K. W. Kinzler:Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 371:75-80 (1995).
110. Ogawa, M.:Differentiation and proliferation of hematopoietic stem cells. Blood, 81:2844-2853 (1993).
111. Ohlsson, R., A. Nystrom, S. Pfeifer-Ohlsson, V. Tohonen, F. Hedborg, P. Schofield, F. Flam, and T. J. Ekstrom:IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedmann syndrome. Nature Genet., 4:94-97 (1993).
112. Oliff, A., O. Agranovsky, M. D. McKinney, V. V. V. S. Murty, and R. B. Bauchwitz:Friend leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus. Proc. Natl. Acad. Sci. U.S.A., 82:3306-3310 (1985).
113. Oren, M., W. Maltzman, and A. J. Levine:Posttranslational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol., 1:101-110 (1981).
114. Osterholz, J., C. R. Dowding, A-P. Guo, M. Siczkowski, and J. M. Goldman:Interferon-α alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myelcid leukemia marrow. Exp. Hematol., 19:326-331 (1991).
115. Pal, N., R. B. Wadey, B. Buckle, E. Yeomans, J. Pritchard, and J. K. Cowell:Preferential loss of maternal alleles in sporadic Wilms' tumor. Oncogene, 5:1665-1668 (1990).
116. + tumor cells. Cell, 75:1227-1236 (1993).
117. Pendergast, A. M., A. J. Muller, A. M. H. Havlik, R. Clark, F. McCormick, and O. N. Witte:Evidence for regulation of the ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. U.S.A., 88:5927-5931 (1991).
118. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. D. N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlassinger, and M. L. Gishizki: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell, 75:175-185 (1993).
119. Pierce, J. H., P. P. Di Fiore, S. A. Aaronson, M. Potter, J. Pumphrey, A. Scott, and J. N. Ihle:Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell, 41:685-693 (1985).
120. Ponticelli, A. S., C. A. Whitlock, N. Rosenberg, and O. N. Witte:In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog. Cell, 29:953-960 (1982).
121. Ponzetto, C. and D. J. Wolgemuth:Haploid expression of a unique c-abl transcript in the mouse male germ line. Mol. Cell, Biol., 5:1791-1794 (1985).
122. Potter, M., M. D. Sklar, and W. P. Rowe:Rapid viral transduction of plasmacytomas in pristane-primed Balb/c mice. Science, 182:592-594 (1973).
123. Prywes, R., G. J. Foulkes, and D. Baltimore:The minimum transforming region of v-abl is the segment encoding protein tyrosine kinase. J. Virol., 54:114-122 (1985).
124. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson:Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway. EMBO J., 13:764-773 (1994).
125. Ratajzcak, M. Z., S. Luger, K. DeRiel, J. Abrahm, B. Calabretta, and A. M. Gewirtz:Acute and chronic phase chronic myelogenous leukemia colony forming units are highly sensitive to the growth inhibitory effect of c-myb antisense oligonucleotides. Blood, 79:1956-1961 (1992).
126. Rees-Jones, R. W., M. Goldfarb, and S. P. Goff:Abelson murine leukemia virus induced platelet-derived growth factor-independent fibroblast growth: correlation with kinase activity and dissociation from full morphologic transformation. Mol. Cell. Biol., 9:278-287 (1989).
127. Reik, W.:Imprinting in leukemia. Nature, 359:362-363 (1992).
128. Renshaw, M. W., M. A. Capozza, and J. Y. J. Wang:Differential expression of type-specific c-abl mRNA in mouse tissues and cell lines. Mol. Cell. Biol., 9:4547-4551 (1988).
129. Renshaw, M. W., E. T. Kipreos, M. R. Albrecht, and J. Y. J. Wang:Oncogenic v-abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J., 11:3941-3951 (1992).
130. Riggins, G. J., S. L. Sherman, C. N. Phillips, W. Stock, C. A. Westbrook, and S. T. Warren:CGG-repeat polymorphism of the BCR gene rules out predisposing alleles leading to the Philadelphia chromosome. Genes Chr. Cancer, 9:141-144 (1994a).
131. Riggins, G. J., F. Zhang, and S. T. Warren:Lack of imprinting of BCR. Nature Genet., 6:226 (1994b).
132. Risinger, J. I., A. Berchuck, M. F. Kohler, P. Watson, H. T. Lynch, and J. Boyd:Genetic instability of microsatellites in endometrial carcinoma. Cancer Res., 53:5100 (1993).
133. Roberts, R., J. Gallagher, E. Spooncer, T. D. Allen, F. Bloomfield, and T. M. Dexter:Heparan sulfate bound growth factors: a mechanism for stromal cell-mediated hemopoiesis. Nature, 332:376-378 (1988).
134. Rohrschneider, L. R.:Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product. Proc. Natl. Acad. Sci. U.S.A., 77:3514-3518 (1980).
135. Rotter, V., M. A. Boss, and D. Baltimore:Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents. J. Virol., 38:336-346 (1981).
136. Rotter, V., O. N. Witte, R. Coffman, and D. Baltimore:Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50. J. Virol., 36:547-555 (1980).
137. Rowley, J. D.:A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243:290-293 (1973).
138. Rowley, J. D.:Ph1-positive leukemia including chronic myelogenous leukemia. Clin. Hematol., 9:55-86 (1980).
139. Sandberg, A. A.:The cytogenetics of CML: chronic phase and blast crisis. Can. Genet. Cytogenet., 1:217 (1980).
140. Sawyers, C. L., W. Callahan, and O. N. Witte:Dominant negative MYC blocks transformation by ABL oncogenes. Cell, 70:901-910 (1992).
141. Scher, C. D. and R. Siegler:Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature, 253:729-731 (1975).
142. Schroeder, W. T., L. Y. Chao, D. D. Dao, L. C. Strong, S. Pathak, V. Riccardi, W. H. Lewis, and G. F. Saunders:Nonrandom loss of maternal chromosome 11 alleles in Wilms tumor. Am. J. Hum. Genet., 40:413-420 (1987).
143. Schwartzberg, P. L., A. M. Stall, J. D. Hardin, K. S. Bowdish, T. Humaran, S. Boast, M. L. Harbison, E. J. Robertson, and S. P. Goff:Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell, 65:1165-1175 (1991).
144. Scrable, H., W. Cavenee, F. Ghavimi, M. Lovell, K. Morgan, and C. Sapienza:A model for embryonal rhabdomyosarcoma tumorigenesis that involves genomic imprinting. Proc. Natl. Acad. Sci. U.S.A., 86:7480-7484 (1989).
145. Shi, L., W. K. Nishioka, J. Th'ng, M. E. Bradbury, D. W. Litchfield, and A. H. Greenberg:Premature p34cdc2 activation required for apoptosis. Science, 263:1143-1145 (1994).
146. Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani:Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature, 315:550-554 (1985).
147. Sirard, C., P. Launeville, and J. E. Dick:Expression of bcr-abl abiogates factor-dependent growth of human hernatopoietic M07E cells by an autocrine mechanism. Blood, 83:1575-1585 (1994).
148. GAP requirement in normal and malignant human hematopoiesis. J. Exp. Med., 178:1923-1933 (1993).
149. Skorski, T., P. Kanakaraj, M. Nieborowska-Skorska, M. Z. Ratajczak, S. C. Wen, G. Zon, A. M. Gewirtz, B. Perussia, and B. Calabretta:Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood, 86:726-736 (1995).
150. Smetsers, T. F. C. M., T. Skorski, L. T. F. van de Locht, H. M. C. Wessels, A. H. M. Pennings, T. de Witte, B. Calabretta, and J. B. M. Mensink:Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. Leukemia, 8:129-140 (1994).
151. Spangrude, G. J., S. Heimgeld, and I. L. Weissman:Purification and characterization of mouse hematopoietic stem cells. Science, 241:58-62 (1988).
152. Stoger, R., P. Kubicka, C. G. Liu, T. Kafri, A. Razin, H. Cedar, and D. P. Barlow:Maternal-specific methylation of the imprinted Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell, 73:61-71 (1993).
153. Strasser, A., A. W. Harris, T. Jacks, and S. Cory:DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79:329-339 (1994).
154. Subler, M. A., D. W. Martin, and S. Deb:Inhibition of viral and cellular promoters by human wild-type p53. J. Virol., 66:4757-4762 (1992).
155. Talpaz, M., H. M. Kantarjian, K. McRedie, J. M. Trujillo, M. J. Keating, and J. U. Gulterman:Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N. Engl. J. Med., 314:1065-1069 (1986).
156. Talpaz, M., H. M. Kantarjian, J. Kursrock, J. M. Trajillo, and J. U. Gutterman:Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann. Intern. Med., 114:532-558 (1991).
157. Tavassoli, M. and C. L. Hardy:Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood, 76:1059-1070 (1990).
158. + leukemia. Blood, 84:1731-1736 (1994).
159. Thibodeau, S. N., G. Bien, and D. Schaid:Microsatellite instability in cancer of the proximal colon. Science, 260:816-819 (1993).
160. Toguchida, J., K. Ishizaki, M. S. Sasaki, Y. Nakamura, M. Ikenaga, M. Kato, M. Sugimot, Y. Kotoura, and T. Yamamuro:Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature, 338:156-158 (1989).
161. Tsujimoto, Y., L. Finger, P. C. Nowell, and C. M. Croce:Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocalion. Science, 226:1097-1099 (1984).
162. Twardzick, D. R. and J. R. Stephenson:Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor. Science, 218:894-897 (1982).
163. Tybulewicz, V. L. J., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan:Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell, 65:1153-1163 (1991).
164. Van Etten, R. A., P. Jackson, and D. Baltimore:The mouse type IV c-abl gene product is a nuclear and activation of transforming ability is associated with cytoplasmic localization. Cell, 58:669-678 (1989).
165. Van Etten, R. A., M. F. Scott, G. Q. Daley, and D. Baltimore:A mouse model for chronic myelogenous leukemia (CML). Blood, 76(Suppl.):247a (1990).
166. Verfaillie, C. M., J. B. McCarthy, and P. B. McGlave:Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J. Exp. Med., 174:693-703 (1991).
167. Verfaillie, C. M., J. B. McCarthy, and P. B. McGlave:Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia, J. Clin. Invest., 90:1232-1241 (1992).
168. Vijayan, V. K., S. H. Advani, and S. M. Zingde:Chronic myeloid leukemic granulocytes exhibit decreased adhesion to fibronectin. Leukemia Res., 18:877-879 (1994).
169. Vuillet-Gaugler, M. H., J. Breton-Gorius, W. Vainchenker, and L. Coloumbel:Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood, 75:865-871 (1990).
170. Wada, C., S. Shionoya, Y. Fujino, H. Tokuhiro, T. Akahoshi, T. Uchida, and H. Ohtani:Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood, 83:3449-3456 (1994).
171. Waneck, G. L. and N. Rosenberg:Abelson leukemia virus induces lymphoid and erythroid colonies in infected fetal cell cultures. Cell, 26:79-89 (1981).
172. Wang, J. Y. J. and D. Baltimore:Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence. Mol. Cell. Biol., 3:773-779 (1983).
173. Wang, J. Y. J.:Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Biol., 3:35-43 (1993).
174. Whitlock, C. A., S. F. Ziegler, and O. N. Witte:Progression of the transformed phenotype in clonal lines of Abelson virus-infected cells. Mol. Cell. Biol., 3:596-604 (1983).
175. Williams, G. T. and C. A. Smith:Molecular regulation of apoptosis: genetic controls of cell death. Cell, 74:777-779 (1993).
176. Williams, G. T., C. A. Smith, E. Spooncer, M. T. Dexter, and D. R. Taylor:Hematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 349:76-79 (1990).
177. Wong, P. M. C., X-D. Han, F. W. Ruscetti, and S. W. Chung:Immortalized hemopoietic cells with stem cell properties. Immunity, 1:571-583 (1994).
178. Wong, P. M. C., A. K. Humphries, T. A. Chen, and C. J. Eaves:Evidence for a multistep pathogenesis in the generation of tumorigenic cell lines from hemopoietic colonies exposed to Abelson virus in vitro. Exp. Hematol., 15:280-287 (1987).
179. Yoder, M. C. and D. A. Williams:Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol., 23:961-967 (1995).
180. Zambetti, G. P., J. Baronetti, K. Walker, C. Prives, and A. J. Levine:Wild-type p53 mediates positive regulation of gene expression through specific DNA sequence element. Genes Dev., 6:1143-1152 (1992).
181. Zhang, Y. and B. Tycko:Monoallelic expression of the human H19 gene. Nature Genet., 1:40-44 (1992).
182. Zhu, X. P., J. M. Dunn, R. A. Phillips, A. D. Goodard, K. E. Paton, A. Becker, and B. L. Gallie:Preferential germline mutation of the paternal allele in retinoblastoma. Nature, 340:312-313 (1989).
183. Zion, M., D. Ben-Yehuda, A. Avraham, O. Cohen, M. Wetzler, D. Melloul, and Y. Ben-Neriah:Progressive de novo methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. U.S.A., 91:10722-10726 (1994).
184. Zuckerman, K. S. and M. S. Wicha:Extracellular matrix production by the adherent cells in long-term murine marrow cultures. Blood, 61:540-547 (1983).